Further action is required to make this featured image accessible
The below criteria must be satisfied:
- Add featured-image alt tag (in page properties OR on image metadata in the dam)
The image will not display until the issue above is resolved.
A study of emergency care involving victims of severe brain trauma is to be performed in this area
The University of Cincinnati is conducting a research study to learn if either of two strategies for monitoring and treating patients with severe traumatic brain injury in the intensive care unit (ICU) is more likely to help them get better. Because head injury is a life threatening condition requiring immediate treatment, some patients will be enrolled without consent if a family member or representative is not rapidly available. Before the study starts, we will consult with the community. We welcome your feedback and questions. For more information or to decline participation in this study, please visit boost3trial.org or contact our study staff at (513) 558-2678.
Primary Investigator: Dr. Natalie Kreitzer MD, Study Coordinator: Pamela Schmit RN BSN
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.